97 related articles for article (PubMed ID: 1373528)
1. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
Duan DS; Smith W; Sadée W; Cowan MJ
Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
[TBL] [Abstract][Full Text] [Related]
2. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
3. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
Yu AL; Bakay B; Kung FH; Nyhan WL
Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
[TBL] [Abstract][Full Text] [Related]
4. Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.
Callard RE; Ewing TM; Fox RM
Clin Exp Immunol; 1984 Oct; 58(1):136-44. PubMed ID: 6236916
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
Seto S; Carrera CJ; Wasson DB; Carson DA
J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
[TBL] [Abstract][Full Text] [Related]
7. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
[TBL] [Abstract][Full Text] [Related]
8. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
9. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes.
Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O
Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516
[TBL] [Abstract][Full Text] [Related]
10. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
[TBL] [Abstract][Full Text] [Related]
11. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
Veit BC; Fishman M; Look T
J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
[TBL] [Abstract][Full Text] [Related]
12. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
Ross DD; Akman SA; Schrecker AW; Bachur NR
Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
[TBL] [Abstract][Full Text] [Related]
13. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
[TBL] [Abstract][Full Text] [Related]
14. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
Thuillier L; Garreau F; Cartier PH
Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
[TBL] [Abstract][Full Text] [Related]
15. Protection by various deoxynucleosides against deoxyadenosine-induced DNA damage in adenosine deaminase-inactivated lymphocytes.
Shimoyama RK; Seto S; Mori C
Mol Genet Metab; 1999 Dec; 68(4):455-60. PubMed ID: 10607474
[TBL] [Abstract][Full Text] [Related]
16. Purine enzyme profile in human colon-carcinoma cell lines and differential sensitivity to deoxycoformycin and 2'-deoxyadenosine in combination.
Camici M; Turriani M; Tozzi MG; Turchi G; Cos J; Alemany C; Miralles A; Noe V; Ciudad CJ
Int J Cancer; 1995 Jul; 62(2):176-83. PubMed ID: 7622293
[TBL] [Abstract][Full Text] [Related]
17. Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
Sheridan W; Gordon DS; Fullen AJ; Olson A; Vogler WR; Winton E
Bone Marrow Transplant; 1989 Sep; 4(5):511-7. PubMed ID: 2790329
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
19. Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukemic cell lines.
Madrid-Marina V; Martinez-Valdez H; Cohen A
Cancer Res; 1990 May; 50(10):2891-4. PubMed ID: 2110502
[TBL] [Abstract][Full Text] [Related]
20. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Niitsu N; Umeda M; Honma Y
Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]